BE N = 291 | NL N = 222 | UK N = 91 | FI N = 269 | IT N = 200 | PL N = 311 | ||
---|---|---|---|---|---|---|---|
N(%) | N(%) | N(%) | N(%) | N(%) | N(%) | P-value* | |
Dementia at time of death (yes)abc | 183 (62.9) | 135 (61.4) | 53 (60.2) | 222 (82.5) | 154 (77.0) | 207 (67.9) | < 0.001 |
Stage of Dementia (based on CPS/GDSd) ab | |||||||
Moderate or mild dementia | 27 (17.1) | 29 (22.3) | 13 (31.0) | 43 (24.2) | 14 (11.7) | 17 (11.3) | 0.676 |
Severe dementia | 48 (30.4) | 41 (31.5) | 11 (26.2) | 57 (32.0) | 40 (33.3) | 37 (24.7) | |
Very severe or advanced dementia | 83 (52.5) | 60 (46.2) | 18 (42.9) | 78 (43.8) | 66 (55.0) | 96 (64.0) | |
Diseases at time of deathbe | |||||||
Malignant cancerb | 30 (15.5) | 27 (18.5) | 9 (42.9) | 41 (19.4) | 26 (17.2) | 10 (4.0) | < 0.001 |
Severe cardiovascular diseaseb | 67 (34.7) | 45 (30.8) | 2 (9.5) | 79 (37.4) | 71 (47.0) | 141 (55.7) | < 0.05 |
Cerebrovascular accident (CVA)b | 40 (20.7) | 25 (17.1) | 3 (14.3) | 49 (23.2) | 34 (22.5) | 70 (27.7) | 0.483 |
Severe pulmonary diseaseb | 33 (17.1) | 17 (11.6) | 3 (14.3) | 17 (8.1) | 40 (26.5) | 18 (7.1) | < 0.001 |
Severe neurological disease (not dementia)b | 15 (7.8) | 11 (7.5) | 0 (0.0) | 26 (12.3) | 18 (11.9) | 32 (12.6) | 0.381 |
Severe renal diseaseb | 19 (9.8) | 19 (13.0) | 2 (9.5) | 13 (6.2) | 22 (14.6) | 29 (11.5) | 0.420 |
Severe diabetesb | 11 (5.7) | 17 (11.6) | 1 (4.8) | 16 (7.6) | 18 (11.9) | 33 (13.0) | 0.177 |
Other severe diseaseb | 31 (16.1) | 4 (2.7) | 3 (14.3) | 51 (24.2) | 33 (21.9) | 33 (13.0) | < 0.001 |
Multimorbidities at time of deathb | |||||||
0–1 long-term conditions | 94 (48.7) | 77 (52.7) | 10 (47.6) | 72 (34.1) | 39 (25.8) | 98 (38.7) | 0.268 |
2 multimorbidities | 54 (28.0) | 40 (27.4) | 8 (38.1) | 68 (32.2) | 52 (34.4) | 102 (40.3) | |
3 multimorbidities | 30 (15.5) | 25 (17.1) | 2 (9.5) | 49 (23.2) | 37 (24.5) | 40 (15.8) | |
4 or more multimorbidities | 15 (7.8) | 4 (2.7) | 1 (4.8) | 22 (10.4) | 23 (15.2) | 13 (5.1) | |
Functional/cognitive status one month before death (BANS-S)af | |||||||
Mean (SD) | 18.5 (4.9) | 17.7 (4.7) | 17.5 (4.2) | 19.6 (4.3) | 21.8 (3.7) | 21.9 (4.6) | < 0.001 |
Cognitive Performance Scale one month before deathag | |||||||
(Borderline) Intact (score 0–1) | 75 (28.0) | 42 (20.5) | 17 (23.3) | 23 (9.4) | 16 (9.9) | 72 (11.6) | < 0.01 |
Mild to moderate impairment (score 2–3) | 55 (20.5) | 58 (28.2) | 21 (28.7) | 56 (22.9) | 27 (16.7) | 37 (15.9) | |
Moderately severe to very severe impairment (score 4–6) | 138 (51.5) | 105 (51.2) | 35 (47.9) | 165 (67.5) | 118 (73.3) | 169 (72.5) | |
Global Deterioration Scale Stage 7 one month before deathah | 155 (57.8) | 104 (47.5) | 40 (50.6) | 111 (48.3) | 124 (66.0) | 208 (73.2) | < 0.001 |
Clinical complications during last month of lifea | |||||||
Pneumoniaa | 64 (24.2) | 75 (37.7) | 16 (21.6) | 76 (31.4) | 45 (25.3) | 62 (21.2) | < 0.01 |
Febrile episode (not pneumonia) a | 118 (44.2) | 36 (18.4) | 4 (5.4) | 78 (31.1) | 98 (52.4) | 136 (46.6) | < 0.001 |
Eating or drinking problema | 179 (65.3) | 125 (60.4) | 41 (51.9) | 170 (66.4) | 113 (60.8) | 198 (66.4) | 0.237 |
Other clinical complications (e.g. stroke)a | 96 (33.0) | 81 (36.5) | 38 (41.8) | 65 (24.2) | 81 (36.5) | 113 (36.3) | < 0.05 |